Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives

[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

(2017) Lien Bekaert et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3

(2016) Haojun Chen et al.   Theranostics

Targeting of MMP2 activity in malignant tumors with a 68 Ga-labeled gelatinase inhibitor cyclic peptide

(2015) Qinghua Liu et al.   NUCLEAR MEDICINE AND BIOLOGY

F-18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for Personalized Cancer Therapy

(2015) Joseph G. Rajendran et al.   SEMINARS IN NUCLEAR MEDICINE

89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment

(2014) S. F. Oosting et al.   JOURNAL OF NUCLEAR MEDICINE

68Ga-PRGD2 PET/CT in the Evaluation of Glioma: A Prospective Study

(2014) Deling Li et al.   MOLECULAR PHARMACEUTICS

The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu

(2014) Artor Niccoli Asabella et al.   Biomed Research International

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

(2012) S De Bruyne et al.   BRITISH JOURNAL OF CANCER

A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer

(2011) Jianguo Zhi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

(2010) X. Lu et al.   CLINICAL CANCER RESEARCH

18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer

(2010) Ashley M. Groves et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy

(2010) X. Sun et al.   JOURNAL OF NUCLEAR MEDICINE

Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM

(2010) Jason L.J. Dearling et al.   NUCLEAR MEDICINE AND BIOLOGY

124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy

(2009) Bernard M. Tijink et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Mode of action and clinical impact of VEGF signaling inhibitors

(2009) Jens Soltau et al.   Expert Review of Anticancer Therapy

The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy

(2009) Katie DeClerck   Frontiers in Bioscience-Landmark

Angiogenesis: An update and potential drug approaches (Review)

(2009) Abdelrahim   INTERNATIONAL JOURNAL OF ONCOLOGY

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis

(2009) Adrian M. Jubb et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

(2009) Axel Grothey et al.   Nature Reviews Clinical Oncology

68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression

(2008) Clemens Decristoforo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Impact of Angiogenesis-Related Gene Expression on the Tracer Kinetics of 18F-FDG in Colorectal Tumors

(2008) L. G. Strauss et al.   JOURNAL OF NUCLEAR MEDICINE